Dr. Lior Carmon

Lior Carmon is an experienced Manager with deep Immunology and Immuno-oncology background


  • Ph.D., Tumor immunology, Weizmann Institute of Science
  • MBA, Ben-Gurion university
  • CLAL Biotech Industries, V.P., Strategic Alliances & Technology Assessment
  • Founder and CEO of a number of clinical stage biotech companies, among them VaxilBio
  • Author of 7 families of granted patents and 16 publications
  • Member of the Editorial Board, International Journal of Cancer Immunology & Immunotherapy

Areas of expertise

  • All areas of biotech strategy and management
  • Business Development
  • Asset valuation
  • Corporate Finance and Marketing
  • Technology assessment